Molecular epidemiology of SARS-CoV-2 in Northern South Africa: wastewater surveillance from January 2021 to May 2022.

RBD mutation analysis SARS-CoV-2 WBE genomic surveillance genetic characterization viral evolution

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 14 10 2023
accepted: 21 11 2023
medline: 4 1 2024
pubmed: 4 1 2024
entrez: 4 1 2024
Statut: epublish

Résumé

Wastewater-based genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides a comprehensive approach to characterize evolutionary patterns and distribution of viral types in a population. This study documents the molecular epidemiology of SARS-CoV-2, in Northern South Africa, from January 2021 to May 2022. A total of 487 wastewater samples were collected from the influent of eight wastewater treatment facilities and tested for SARS-CoV-2 RNA using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). SARS-CoV-2 positive samples with genome copies/mL ≥1,500 were subjected to allele-specific genotyping (ASG) targeting the Spike protein; 75 SARS-CoV-2 positive samples were subjected to whole genome sequencing (WGS) on the ATOPlex platform. Variants of concern (VoC) and lineages were assigned using the Nextclade and PangoLIN Software. Concordance for VoC between ASG and WGS analyses was determined. Sequence relationship was determined by phylogenetic analysis. Seventy-five percent (365/487) of the influent samples were positive for SARS-CoV-2 RNA. Delta and Omicron VoC were more predominant at a prevalence of 45 and 32%, respectively, and they were detected as early as January and February 2021, while Beta VoC was least detected at a prevalence of 5%. A total of 11/60 (18%) sequences were assigned lineages and clades only, but not a specific VoC name. Phylogenetic analysis was used to investigate the relationship of these sequences to other study sequences, and further characterize them. Concordance in variant assignment between ASG and WGS was seen in 51.2% of the study sequences. There was more intra-variant diversity among Beta VoC sequences; mutation E484K was absent. Three previously undescribed mutations (A361S, V327I, D427Y) were seen in Delta VoC. The detection of Delta and Omicron VoCs in study sites earlier in the outbreak than has been reported in other regions of South Africa highlights the importance of population-based approaches over individual sample-based approaches in genomic surveillance. Inclusion of non-Spike protein targets could improve the specificity of ASG, since all VoCs share similar Spike protein mutations. Finally, continuous molecular epidemiology with the application of sensitive technologies such as next generation sequencing (NGS) is necessary for the documentation of mutations whose implications when further investigated could enhance diagnostics, and vaccine development efforts.

Identifiants

pubmed: 38174083
doi: 10.3389/fpubh.2023.1309869
pmc: PMC10764116
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1309869

Informations de copyright

Copyright © 2023 Tambe, Mathobo, Matume, Munzhedzi, Edokpayi, Viraragavan, Glanzmann, Tebit, Mavhandu-Ramarumo, Street, Johnson, Kinnear and Bessong.

Déclaration de conflit d'intérêts

DT was employed by Global Biomed Laboratories Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Lisa Arrah Mbang Tambe (LAM)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Department of Biochemistry and Microbiology, University of Venda, Thohoyandou, South Africa.

Phindulo Mathobo (P)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Department of Biochemistry and Microbiology, University of Venda, Thohoyandou, South Africa.

Nontokozo D Matume (ND)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg, South Africa.

Mukhethwa Munzhedzi (M)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Department of Biochemistry and Microbiology, University of Venda, Thohoyandou, South Africa.

Joshua Nosa Edokpayi (JN)

Water and Environmental Management Research Group, University of Venda, Thohoyandou, South Africa.

Amsha Viraragavan (A)

South African Medical Research Council Genomics Platform, Tygerberg, South Africa.

Brigitte Glanzmann (B)

South African Medical Research Council Genomics Platform, Tygerberg, South Africa.

Denis M Tebit (DM)

Global Biomed Laboratories Inc., Lynchburg, VA, United States.

Lufuno Grace Mavhandu-Ramarumo (LG)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Department of Biochemistry and Microbiology, University of Venda, Thohoyandou, South Africa.

Renee Street (R)

Environment and Health Research Unit, South African Medical Research Council, Johannesburg, South Africa.

Rabia Johnson (R)

Biomedical Research and Innovation Platform, South African Medical Research Council, Cape Town, South Africa.
Division of Medical Physiology, Faculty of Medicine and Health Sciences, Centre for Cardiometabolic Research in Africa, Stellenbosch University, Stellenbosch, South Africa.

Craig Kinnear (C)

South African Medical Research Council Genomics Platform, Tygerberg, South Africa.

Pascal Obong Bessong (PO)

HIV/AIDS & Global Health Research Programme, University of Venda, Thohoyandou, South Africa.
Center for Global Health Equity, School of Medicine, University of Virginia, Charlottesville, VA, United States.
School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Classifications MeSH